The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.

The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results. J Invasive Cardiol. 2003 Nov; 15(11):611-6.

View in: PubMed

subject areas

Aged
Angina, Unstable
Angioplasty, Balloon, Coronary
Anticoagulants
Female
Heparin
Hirudins
Humans
Male
Middle Aged
Myocardial Infarction
Peptide Fragments
Prospective Studies
Recombinant Proteins
Thrombocytopenia
Treatment Outcome

authors with profiles

Robert Harrington